|
WO2021034727A1
|
|
Compositions, formulations, and interleukin production and purification
|
|
WO2021034728A1
|
|
Compositions and particles for payload delivery
|
|
US2020140511A1
|
|
Delivery constructs for transcytosis and related methods
|
|
EP3650037A1
|
|
Delivery constructs for transcytosis and related methods
|
|
TW202031678A
|
|
Delivery constructs for transcytosis and related methods
|
|
WO2020096695A1
|
|
Cholix-derived carriers for oral delivery of heterologous payload
|
|
AU2019230230A1
|
|
Toxin-derived delivery constructs for oral delivery
|
|
CN112105376A
|
|
Toxin-derived delivery constructs for oral delivery
|
|
US2017151307A1
|
|
Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
|
